Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prioritization of drug targets for thyroid cancer: a multi-omics Mendelian randomization study.

Endocrine - 1 Nov 2024

Sun Hong, Li Ling, Yan Jingchao, Huang Taomin

Abstract excerpt

OBJECTIVES: Recurrence or tumor metastasis and drug resistance remain the major challenge in the treatment of thyroid cancer. It is needed to identify novel drug targets for thyroid cancer. METHODS: Summary data-based Mendelian randomization (SMR) and colocalization analysis were performed to evaluate the associations between gene methylation, expression, protein levels with thyroid cancer. We additionally...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to Genetic Predisposition to Disease
Share to Mendelian Randomization Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiomics

Share to Protein Interaction Maps

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Vascular Cell Adhesion Molecule-1

Source

Identifiers

PMID: 38896366
DOI: 10.1007/s12020-024-03933-x

Genes

SDCCAG8
TCN2
VCAM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prioritization of drug targets for thyroid cancer: a multi-omics Mendelian randomization study.PMID 38896366Read ↗

Causal role of immune cells in thyroid cancer: a bidirectional Mendelian randomization study.Semantic proximity Read ↗

Plasma proteome mendelian randomization and network pharmacology reveal therapeutic targets for thyroid disorders.Semantic proximity Read ↗

Multi-omics clustering analysis carries out the molecular-specific subtypes of thyroid carcinoma: implicating for the precise treatment strategies.Semantic proximity Read ↗

Multi-omics clustering analysis carries out the molecular specific subtypes of thyroid carcinoma: implicating for the precise treatment strategiesSemantic proximity Read ↗

Identification of novel cholesterol metabolism-related biomarkers for thyroid cancer to predict the prognosis, immune infiltration, and drug sensitivitySemantic proximity Read ↗

Novel a new prognostic model of Thyroid Carcinoma based on Macrophage and Cuproptosis-Related lncRNASemantic proximity Read ↗

Genomics and Multi-Omics to Guide Clinical Management in Thyroid CancerSemantic proximity Read ↗

Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-EnvironmentSemantic proximity Read ↗

Causal role of immune traits and inflammatory proteins in autoimmune thyroid disease: Mendelian randomization studySemantic proximity Read ↗

Potential drug targets for tumors identified through Mendelian randomization analysis.Semantic proximity Read ↗

Identification of lncRNAs and immune-related prognostic genes as thyroid cancer microenvironment biomarkersSemantic proximity Read ↗

In silico evaluation of the role of the long non-coding RNA LINC00092 in thyroid cancer progression ; regulation of the miR-34a-5p/RCAN1 axisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.